TY  - GEN
AU  - Hagenbeek,A
AU  - Carde,P
AU  - Meerwaldt,J H
AU  - Somers,R
AU  - Thomas,J
AU  - De Bock,R
AU  - Raemaekers,J M
AU  - van Hoof,A
AU  - De Wolf-Peeters,C
AU  - van Glabbeke,M
TI  - Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group
SN  - 0732-183X
PY  - 1998///0127
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Cyclophosphamide
KW  - administration & dosage
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Lymphoma, Non-Hodgkin
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Neoplasm, Residual
KW  - Prednisone
KW  - Prospective Studies
KW  - Recombinant Proteins
KW  - Remission Induction
KW  - Survival Analysis
KW  - Vincristine
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1200/JCO.1998.16.1.41
ER  -